miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1

BackgroundmicroRNAs (miRNAs) are a class of small non-coding RNAs that play important roles in carcinogenesis. In the present study, we investigated the effect of miR-212 on pancreatic ductal adenocarcinoma (PDAC) and its target protein.MethodsQuantitative real-time PCR(qRT-PCR) was performed to detect the expression of miR-212 in PDAC tissues and pancreatic cancer cell lines. miR-212 mimic, miR-212 inhibitor and negative control were transfected into pancreatic cancer cells and the effect of miR-212 up-regulation and down-regulation on the proliferation, migration and invasion of cells were investigated. Furthermore, the mRNA and protein levels of Patched-1(PTCH1) were measured. Meanwhile, luciferase assays were performed to validate PTCH1 as miR-212 target in PDAC.ResultsmiR-212 was up-regulated in PDAC tissues and cells.Using both gain-of function and loss-of function experiments, a pro-oncogenic function of miR-212 was demonstrated in PDAC. Moreover, up-regulated of PTCH1 could attenuate the effect induced by miR-212.ConclusionThese data suggest that miR-212 could facilitate PDAC progression and metastasis through targeting PTCH1, implicating a novel mechanism for the progression of PDAC.

[1]  C. Bracken,et al.  The role of microRNAs in metastasis and epithelial-mesenchymal transition , 2009, Cellular and Molecular Life Sciences.

[2]  J. Lv,et al.  PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer , 2010, Upsala journal of medical sciences.

[3]  Xiao-li Zhang,et al.  Activation of the hedgehog pathway in a subset of lung cancers. , 2006, Cancer letters.

[4]  Y. Kodera,et al.  PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. , 2006, Anticancer research.

[5]  H. Phillip Koeffler,et al.  Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer , 2007, Breast Cancer Research and Treatment.

[6]  Mohamed Guled,et al.  Mikro-RNA:t ja syöpä , 2013 .

[7]  A. Palmieri,et al.  MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression , 2010, International journal of immunopathology and pharmacology.

[8]  R. Weinberg,et al.  Micromanagers of malignancy: role of microRNAs in regulating metastasis. , 2008, Trends in genetics : TIG.

[9]  Ling Xu,et al.  Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells , 2011, Medical oncology.

[10]  Chi-Chung Hui,et al.  Hedgehog signaling in development and cancer. , 2008, Developmental cell.

[11]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[12]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[13]  Y. Huang,et al.  MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1 , 2012, Molecular biology of the cell.

[14]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[15]  Q. Wang,et al.  Expression patterns and polymorphisms of PTCH in Chinese hepatocellular carcinoma patients. , 2008, Experimental and molecular pathology.

[16]  Y. Gong,et al.  Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer , 2006, Gene Therapy.

[17]  G. Skogerbø,et al.  7. microRNAs and Cancer , 2013 .

[18]  K. Hirata,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology Transcriptional Control of Tight Junction Proteins via a Protein Kinase C Signal Pathway in Human Telomerase Reverse Transcriptase-Transfected Human Pancreatic Duct Epithelial Cells , 2010 .

[19]  Wei Gong,et al.  Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance , 2013, Journal of experimental & clinical cancer research : CR.

[20]  H. Osada,et al.  MicroRNAs in biological processes and carcinogenesis. , 2007, Carcinogenesis.

[21]  Frank McCormick,et al.  Activation of the hedgehog pathway in advanced prostate cancer , 2004, Molecular Cancer.

[22]  F. Kisseljov.  MicroRNAs and cancer , 2014, Molecular Biology.

[23]  A. Roccaro,et al.  Regulation of microRNAs in cancer metastasis. , 2014, Biochimica et biophysica acta.

[24]  Jiping Zeng,et al.  Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212 , 2013, PloS one.

[25]  Wei Wu,et al.  Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues , 2012, Journal of experimental & clinical cancer research : CR.

[26]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[27]  Liu Zhifang,et al.  MicroRNA‐212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2 , 2013, Journal of cellular biochemistry.

[28]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[29]  Wenlin Huang,et al.  Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. , 2013, Gastroenterology.

[30]  Peter A. Pinto,et al.  Comprehensive microRNA Profiling of Prostate Cancer , 2013, Journal of Cancer.

[31]  S. Knuutila,et al.  [MicroRNAs and cancer]. , 2013, Duodecim; laaketieteellinen aikakauskirja.

[32]  Yuriy Gusev,et al.  miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. , 2011, Biochemical and biophysical research communications.

[33]  M. Scott,et al.  The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog , 1996, Nature.

[34]  Yu-rong Shi,et al.  MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells , 2012, Journal of Experimental & Clinical Cancer Research.

[35]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[36]  Michael T. McManus,et al.  MicroRNAs and cancer. , 2003, Seminars in cancer biology.